Clinical Trials Sponsored by Michael macknin

Total 739 results

Michael A. Nauck

Completed

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Type 2 Diabetes

Germany
Michael Wolzt, Prof. MD

Completed

The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment

Ischemia

Austria
Michael A. Nauck

Completed

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Type 2 Diabetes

Germany
Michael A. Nauck

Completed

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Diabetes

Germany
Michael Rapoff, Ph.D.

Completed

Jointstrong Intervention for Juvenile Arthritis

Juvenile Arthritis

United States
Michael E. DeBakey VA Medical Center
Solvay Pharmaceuticals

Completed

Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone

Hypogonadism | Alzheimer's Disease

United States
Michael Ayers
Bristol-Myers Squibb

Not yet recruiting

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM (MavaPET)

Obstructive Hypertrophic Cardiomyopathy

United States
Michael Tsoukas
Adocia

Recruiting

Safety and Efficacy of BC LisPram

Type1 Diabetes Mellitus

Canada
Michael Khazzam

Not yet recruiting

Effectiveness of Corticosteroid vs Ketorolac Shoulder Injections

Rotator Cuff Tendinitis | Full-thickness Rotator Cuff Tear

United States
Michael Irwin, MD

Recruiting

Sleep and Healthy Aging Research for Depression (SHARE-D) Study (SHARE-D)

Depression in Old Age

United States
Professor Michael Bourke

Recruiting

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach (OERS)

Adenoma, Villous

Australia
Zachariah Michael DeFilipp
Regimmune Corporation

Active, not recruiting

Haplo Peripheral Blood Sct In GVHD Prevention

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | AML | Non Hodgkin Lymphoma | MDS | Myeloproliferative Disorder | GVHD | Graft Vs Host Disease | ALL | CMML | Blood Stem Cell Transplant Failure | MPN | Chemosensitive Hodgkin Lymphoma

United States
Professor Michael Bourke

Completed

Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection (RESDEMR)

Colonic Polyps

Australia
Professor Michael Bourke

Withdrawn

Long Term Barrett's Endoscopic Mucosal Resection Study (CBE)

Barretts Esophagus

Australia
Professor Michael Bourke

Completed

Failed/Difficult Colonoscopy Outcomes (FoDCO)

Colonoscopy

Australia
Michael Gunn
National Cancer Institute (NCI)

Withdrawn

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM (DEMAND)

Glioblastoma | Glioma, Malignant

United States
Professor Michael Bourke

Completed

Fully Coated, Removable, Self-expanding Oesophageal Stents for Preventing Strictures Following Complete Barretts Excision. (CBE-001-SEOS)

Constriction, Pathological

Australia
Professor Michael Bourke

Completed

Soft Coagulation for the Prevention of Adenoma Recurrence (SCAR)

Colonic Adenomas

Australia
Professor Michael Bourke

Completed

Cold Polypectomy Site Study

Colonic Polyps

Australia
Dr. Michael Esser
NeuroCatch Inc.

Unknown

Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion

Traumatic Brain Injury | Pediatric ALL | Children, Only | Concussion, Mild

Canada
Michael A. Nauck

Completed

Carbohydrates to Prevent Hypoglycaemia During Physical Activity in Patients With Type 1 Diabetes

Hypoglycaemia

Germany
Mina Micheal Anwer Fahmy

Unknown

Repair of Flexor Tendon Injuries With Eight Strand Core Stitch Without Postoperative Splinting

Flexor Tendon Repair
Caroline Michaela Kistorp
Sanofi

Not yet recruiting

Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease (FORTIFY)

Chronic Kidney Diseases | Fabry Disease

Denmark
Michaela Liedtke
Celgene Corporation

Completed

Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Michaël RACODON

Recruiting

Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) (CHRONOBIO)

Respiratory Diseases

France
Michael, Levy M.D.,Ph.D.
Jazz Pharmaceuticals

Not yet recruiting

A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders (SENS-NMO)

Spasticity, Muscle | NMO Spectrum Disorder

United States
Michael Fu
Göteborg University; AstraZeneca

Recruiting

OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF)

Heart Failure | Hyperkalemia

Sweden
Michael C Willey
Orthopaedic Trauma Association

Completed

Trauma Screening and Supplementation

Trauma | Wound Heal | Nutritional Deficiency

United States
Michael Boyiadzis
Merck Sharp & Dohme LLC

Completed

A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML

Acute Myeloid Leukemia

United States
Prof. Michael B. Zimmermann

Unknown

Iron Long-Term Labelling Study Benin

Iron Absorption

Benin
Norconnect Inc
Michael J. Fox Foundation for Parkinson's Research

Completed

Electromyography Signals as Biomarkers for Parkinson's Disease

Parkinson's Disease

United States
Michael Morse, MD
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Testicular Germ Cell Tumor | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Liver Cancer | Gallbladder Cancer

United States
Michel Burnier

Completed

Treatment Adhesion in Dialysis Patients Treated With Cinacalcet (MEMS-cinac)

Hyperparathyroidism | Chronic Kidney Disease

Switzerland
Michal Nowicki

Available

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Thrombotic Microangiopathy
Jean Michel Hascoet
Maternite Regionale Universitaire

Completed

Prematurity Related Risks of Cognitive Impairment at School Age (NEORIS)

Complications of Prematurity

France
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Recruiting

A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Parkinson Disease

United States
Yale University
Fox (Michael J.) Foundation for Parkinson's Research

Recruiting

Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

Depression | Parkinson's Disease

United States
Michael Marchand, MD
Université de Montréal

Recruiting

Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

Conjunctivitis, Allergic | Conjunctivitis, Vernal

Canada
Michael Frass
Sigmund Freud PrivatUniversitat

Completed

Use of Homeopathy in Patients Suffering From Long COVID-19 (LONGCOVIHOM)

Adjustment Reaction With Physical Symptoms

Austria
Michael Choi
Pharmacyclics LLC.

Active, not recruiting

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Avanir Pharmaceuticals
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (LID in PD)

Parkinson's Disease | Dyskinesia

Canada, United States
Michael Cohen-Wolkowiez
The Emmes Company, LLC

Completed

Antibiotic Safety (SCAMP) (SCAMP)

Complicated Intra Abdominal Infections

United States, Canada
Michael Choi
Pharmacyclics LLC.

Withdrawn

Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib.

Chronic Lymphocytic Leukemia
Prof. Michael B. Zimmermann

Unknown

Iron Long-Term Labelling Study Switzerland

Iron Absorption

Switzerland
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Idiopathic Parkinson's Disease

Israel, Serbia, United Kingdom
Bastyr University
Michael J. Fox Foundation for Parkinson's Research

Completed

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease ((in)GSH)

Parkinson's Disease

United States
Michael Rickels
University of Pennsylvania

Completed

Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction

Normal Non-fluency

United States
Weintraub, Michael I., MD, FACP, FAAN
Nu-Magnetics Inc.

Unknown

Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy

Diabetic Neuropathies

United States
Murphy, Michael P., MD
Indiana University School of Medicine

Unknown

Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease

Peripheral Vascular Diseases

United States
Jean Michel Hascoet

Completed

Effect of Prematurity on Renal Function in 5 Years Old Children (SUIVIREIN)

Prematurity of Fetus

France

Clinical Trials Sponsored by Michael macknin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations